MedTrace Logo

Prunes for Gastrointestinal Function After Gynecologic Surgery

NCT03523715 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2021-04-08

Study results available
· View outcomes & findings →

Summary

This is a prospective, randomized control trial that randomizes patients post-operatively into standard care versus standard care plus prunes. Patients in the control arm will take 100 mg docusate twice per day for 3 days (standard care). Participants in the treatment arm will consume 4 oz prunes daily and take 100 mg docusate twice per day for 3 days. The primary objective is to determine the time to first bowel movement after surgery.

Conditions

Interventions

DIETARY_SUPPLEMENT

Prunes

12 oz of prunes daily

DRUG

Docusate Sodium

Oral docusate sodium twice daily

Sponsors & Collaborators

  • University of Southern California

    lead OTHER

Principal Investigators

  • Begum Ozel, MD · Keck School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-30
Primary Completion
2020-06-30
Completion
2020-07-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03523715 on ClinicalTrials.gov